Skip to main content
OpenTrials

Clinical trial condition

Fallopian Tube Neoplasms

Explore clinical trials studying Fallopian Tube Neoplasms. Study availability and eligibility vary by location and protocol.

600 public trials 90 recruiting studies
Refine in advanced search Browse all conditions

Fallopian Tube Neoplasms trial results

Completed

Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients

NCT04227522

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +23 more
Locations
  • Universitätsklinikum Aachen Aachen, Germany
  • ANregiomed Frauenklinik Ansbach Ansbach, Germany
  • Helios Klinikum Berlin-Buch Berlin, Germany
  • Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum Berlin, Germany
View all 17 locations
View Trial Details
Completed

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

NCT03345485

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +50 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • New York University New York, United States
View all 13 locations
View Trial Details
Completed

A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT03635489

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Beijing Obstetrics and Gynecology Hospital, Capital Medical University Beijing, China
  • the First Hospital of Jilin University Changchun, China
  • Jilin Cancer Hospital Changchun, China
  • Xiangya Hospital Central South University Changsha, China
View all 16 locations
View Trial Details
Completed

Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer

NCT02480374

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • University of Alabama Birmingham Cancer Center Birmingham, Alabama, United States
  • Washington Univ. in St. Louis/Barnes Jewish Hospital St Louis, Missouri, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Medical College of Wisconsin/Froedtert Hospital Milwaukee, Wisconsin, United States
View Trial Details
Completed

Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)

NCT03648489

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +22 more
Locations
  • Charité Universitätsmedizin Berlin Berlin, Germany
  • Universitätsklinikum Carl Gustav Carus Dresden Dresden, Germany
  • KEM Kliniken Essen-Mitte Essen, Germany
  • Furness General Hospital Barrow in Furness, Cumbria, United Kingdom
View all 15 locations
View Trial Details
Completed

Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.

NCT02903771

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +19 more
Locations
  • Peggy and Charles Stephenson Cancer Center, OU Health Sciences Center Oklahoma City, Oklahoma, United States
  • Lifespan Cancer Institute, Rhode Island Hospital Providence, Rhode Island, United States
  • Mary Crowley Cancer Research Center Dallas, Texas, United States
  • Westmead Adults Hospital Westmead, New South Wales, Australia
View Trial Details
Completed

A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression

NCT04296890

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Arizona Oncology Associates Phoenix, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • California Cancer Associates (cCARE) Fresno, California, United States
  • Stanford School of Medicine Palo Alto, California, United States
View all 89 locations
View Trial Details
Completed

Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian Cancer

NCT03759600

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • Hirosaki University Hospital Hirosaki, Aomori, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • The Jikei University Kashiwa Hospital Kashiwa, Chiba, Japan
View all 33 locations
View Trial Details

Related conditions